Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and Papilloma

quinazolines has been researched along with Papilloma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ashton, GH; Baldeschi, C; Brunton, VG; Canel, M; Doyle, B; Frame, MC; Green, TP; Mackintosh, LJ; Mason, SM; Sansom, OJ; Serrels, A; Serrels, B1
Batra, RK; Dubinett, SM; Limsukon, A; Soo Hoo, GW; Susanto, I1
BALDWIN, RW; CUNNINGHAM, GJ; DEAN, HG; PARTRIDGE, MW; SURTEES, SJ; VIPOND, HJ1
Bostrom, B; Drehner, D; Lander, T; Marker, S; Sidman, J1

Other Studies

4 other study(ies) available for quinazolines and Papilloma

ArticleYear
A novel Src kinase inhibitor reduces tumour formation in a skin carcinogenesis model.
    Carcinogenesis, 2009, Volume: 30, Issue:2

    Topics: Adult; Aged; Animals; Anticarcinogenic Agents; Benzodioxoles; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Disease Models, Animal; Female; Humans; Keratinocytes; Keratosis; Male; Mice; Middle Aged; Papilloma; Precancerous Conditions; Quinazolines; Skin Neoplasms; src-Family Kinases; Tetradecanoylphorbol Acetate

2009
Regression of recurrent respiratory papillomatosis with celecoxib and erlotinib combination therapy.
    Chest, 2009, Volume: 136, Issue:3

    Topics: Biopsy; Bronchoscopy; Celecoxib; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Erlotinib Hydrochloride; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Papilloma; Protein Kinase Inhibitors; Pyrazoles; Quinazolines; Sulfonamides

2009
FURTHER STUDIES ON THE INFLUENCE OF PERIPHERAL RING SUBSTITUTION ON THE CARCINOGENICITY OF TRICYCLOQUINAZOLINE.
    Biochemical pharmacology, 1965, Volume: 14

    Topics: Carcinogens; Chemistry, Pharmaceutical; Heterocyclic Compounds; Mice; Neoplasms, Experimental; ortho-Aminobenzoates; Papilloma; Pharmacology; Quinazolines; Research; Skin Neoplasms; Toxicology

1965
Gefitinib therapy for life-threatening laryngeal papillomatosis.
    Archives of otolaryngology--head & neck surgery, 2005, Volume: 131, Issue:1

    Topics: Adolescent; Antiviral Agents; Bronchoscopy; ErbB Receptors; Gefitinib; Humans; Laryngeal Neoplasms; Male; Papilloma; Papillomavirus Infections; Protein Kinase Inhibitors; Quinazolines; Recurrence; Treatment Outcome

2005